What is Avid Bioservices Cash Flow from Financing?
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
three
months ended in Oct. 2024,
Avid Bioservices paid€0.0 Mil more to buy back shares than it received from issuing new shares.
It spent€0.6 Mil paying down its debt.
It paid€0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It received€0.0 Mil from paying cash dividends to shareholders.
It received€0.1 Mil on other financial activities.
In all, Avid Bioservicesspent€0.5 Mil on financial activities for the
three
months ended in Oct. 2024.
Avid Bioservices Cash Flow from Financing Historical Data
The historical data trend for Avid Bioservices's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avid Bioservices Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Avid Bioservices's Cash from Financing for the fiscal year that ended in Apr. 2024 is calculated as:
Cash Flow from Financing for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €10.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avid Bioservices (STU:TEHN) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Avid Bioservices's issuance of stock for the
three
months ended in Oct. 2024 was €0.0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Avid Bioservices's repurchase of stock for the
three
months ended in Oct. 2024 was €0.0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Avid Bioservices's net issuance of debt for the
three
months ended in Oct. 2024 was €-0.6 Mil.
Avid Bioservices spent€0.6 Mil paying down its debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Avid Bioservices's net issuance of preferred for the
three
months ended in Oct. 2024 was €0.0 Mil.
Avid Bioservices paid€0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Avid Bioservices's cash flow for dividends for the
three
months ended in Oct. 2024 was €0.0 Mil.
Avid Bioservices received€0.0 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Avid Bioservices's other financing for the
three
months ended in Oct. 2024 was €0.1 Mil.
Avid Bioservices received€0.1 Mil on other financial activities.
Avid Bioservices Cash Flow from Financing Related Terms
Thank you for viewing the detailed overview of Avid Bioservices's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:TEHN has been successfully added to your 